Divergent gender identity in three siblings with 46XX karyotype and severely virilizing congenital adrenal hyperplasia caused by a novel CYP11B1 mutation.

OBJECTIVE To describe conflicting gender identities in three karyotypically female siblings with congenital adrenal hyperplasia (CAH) caused by a novel mutation in the CYP11B1 gene, who were assigned as males at birth and followed up to adulthood. METHODS We present 3 siblings (16, 14 and 10 years old) who were born with severe genital virilization and raised as males. Clinical examination showed Prader IV to V external genitalia with a stretched penile length of 7 to 11 cm. Adrenocorticotrophic hormone (ACTH) stimulation test showed a stimulated 11 deoxycortisol (11DOC) level of 12,300-18,700 μg/L (normal 0-5 μg/L). Their karyotypes were 46 XX, and they had normal-sized uterus and ovaries on pelvic ultrasound. DNA was isolated from peripheral leukocytes, and polymerase chain reaction (PCR) and direct sequencing revealed a novel CYP11B1 mutation. This mutation leads to a c.53_54 T insertion (c.53_54insT) with frameshift and truncation at c.115 (codon 39) of CYP11B1. RESULTS Psychological evaluation of the oldest sibling suggested a female gender identity, and she declared herself as female, and female sex was re-assigned after 1 year of psychosocial adjustment. Psychological assessment for the 2 younger siblings and a fourth 46XY sibling with the same condition revealed male gender identities, and they continued their lives as males without significant difficulties. CONCLUSION Divergent gender identity was observed in three severely masculinized 46XX siblings with CAH who carried the same CYP11B1 mutation and had comparable postnatal and probably prenatal androgen exposure and environmental circumstances. These cases suggest that the basis of gender identity is more complex than chromosomal, biochemical, and genetic constitution.

[1]  R. Seyam,et al.  Long-term outcome of genital reconstruction of Middle Eastern women with congenital adrenal hyperplasia , 2013, Urology annals.

[2]  Weiqing Wang,et al.  A prevalent and three novel mutations in CYP11B1 gene identified in Chinese patients with 11-beta hydroxylase deficiency , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  M. Hashemipour,et al.  Two novel mutations in CYP11B1 and modeling the consequent alterations of the translated protein in classic congenital adrenal hyperplasia patients , 2013, Endocrine.

[4]  P. Miettinen,et al.  Gender identity and gender role orientation in female assigned patients with disorders of sex development. , 2012, The Journal of urology.

[5]  M. Gribaa,et al.  Two novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11β hydroxylase deficiency in a Tunisian family. , 2012, General and comparative endocrinology.

[6]  Peter A. Lee,et al.  Review of Outcome Information in 46,XX Patients with Congenital Adrenal Hyperplasia Assigned/Reared Male: What Does It Say about Gender Assignment? , 2010, International journal of pediatric endocrinology.

[7]  J. Grötzinger,et al.  Congenital Adrenal Hyperplasia due to 11-Hydroxylase Deficiency – Insights from Two Novel CYP11B1 Mutations (p.M92X, p.R453Q) , 2009, Hormone Research in Paediatrics.

[8]  M. de Castro,et al.  Novel mutations in CYP11B1 gene leading to 11 beta-hydroxylase deficiency in Brazilian patients. , 2009, The Journal of clinical endocrinology and metabolism.

[9]  M. New,et al.  Sexual Orientation in Women with Classical or Non-classical Congenital Adrenal Hyperplasia as a Function of Degree of Prenatal Androgen Excess , 2008, Archives of sexual behavior.

[10]  Peter A. Lee,et al.  46,XX Patients with Congenital Adrenal Hyperplasia: Initial Assignment as Male, Reassigned Female , 2005, Journal of pediatric endocrinology & metabolism : JPEM.

[11]  U. Kuhnle,et al.  The Impact of Culture on Sex Assignment and Gender Development in Intersex Patients , 2002, Perspectives in biology and medicine.

[12]  H. Wollmann,et al.  Complete virilization in congenital adrenal hyperplasia: clinical course, medical management and disease‐related complications , 2002, Clinical endocrinology.

[13]  H. Meyer-Bahlburg What causes low rates of child-bearing in congenital adrenal hyperplasia? , 1999, The Journal of clinical endocrinology and metabolism.

[14]  J. Baron,et al.  Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency. , 1998, The Journal of clinical endocrinology and metabolism.

[15]  M. Diamond,et al.  Sex Reassignment at Birth: Long-term Review and Clinical Implications , 1997 .

[16]  R. Kofler,et al.  CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. , 1996, The Journal of clinical endocrinology and metabolism.

[17]  G. Rumsby,et al.  Steroid 11 beta-hydroxylase deficiency caused by a five base pair duplication in the CYP11B1 gene. , 1994, Human Molecular Genetics.

[18]  P. White,et al.  Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Kofler,et al.  Frame shift by insertion of 2 basepairs in codon 394 of CYP11B1 causes congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency. , 1992, The Journal of clinical endocrinology and metabolism.

[20]  R. Dittmann,et al.  Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia , 1992, Psychoneuroendocrinology.